The frequency of CD14+CD163+ MNPs is higher in UC relative to CD or non-IBD patients in MLNs and enriched in bona fide MERTK+MARCOhighCD169−HLA-DRhi Mɸ and CD11b+TREM1+HLA-DRdim cells [66]. This evidence concerns the gene MERTK and inflammatory bowel disease.